Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus - Raz_2006_Diabetologia_49_2564 |
Author(s) : Raz I , Hanefeld M , Xu L , Caria C , Williams-Herman D , Khatami H |
Ref : Diabetologia , 49 :2564 , 2006 |
Abstract :
AIMS/HYPOTHESIS: The aim of this study was to assess the efficacy and safety of sitagliptin (MK-0431) as monotherapy in patients with type 2 diabetes mellitus and inadequate glycaemic control (HbA(1c) > or =7% and < or =10%) on exercise and diet. |
PubMedSearch : Raz_2006_Diabetologia_49_2564 |
PubMedID: 17001471 |
Inhibitor | Sitagliptin |
Raz I, Hanefeld M, Xu L, Caria C, Williams-Herman D, Khatami H (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
Diabetologia
49 :2564
Raz I, Hanefeld M, Xu L, Caria C, Williams-Herman D, Khatami H (2006)
Diabetologia
49 :2564